Truist raised the firm’s price target on American Healthcare REIT (AHR) to $53 from $46 and keeps a Buy rating on the shares. The firm is raising its FFO estimates and price target following strong results and higher earnings guidance, the analyst tells investors in a research note. American Healthcare REIT appears very well positioned to benefit from favorable industry trends, the firm added.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT Closes Public Stock Offering
- American Healthcare REIT 8.1M share Spot Secondary priced at $48.00
- American Healthcare REIT price target raised to $52 from $45 at Citi
- American Healthcare REIT 8.1M share Spot Secondary; price range $48.00-$48.60
- American Healthcare REIT announces offering of 8.1M shares of common stock